227 related articles for article (PubMed ID: 18220763)
1. Type 2 diabetes and oral antihyperglycemic drugs.
Mizuno CS; Chittiboyina AG; Kurtz TW; Pershadsingh HA; Avery MA
Curr Med Chem; 2008; 15(1):61-74. PubMed ID: 18220763
[TBL] [Abstract][Full Text] [Related]
2. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
Fisman EZ; Tenenbaum A; Motro M; Adler Y
Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
[TBL] [Abstract][Full Text] [Related]
3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
Krentz AJ; Bailey CJ
Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
[TBL] [Abstract][Full Text] [Related]
4. Oral antidiabetic agents in type 2 diabetes.
Levetan C
Curr Med Res Opin; 2007 Apr; 23(4):945-52. PubMed ID: 17407651
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database].
Umetsu R; Nishibata Y; Abe J; Suzuki Y; Hara H; Nagasawa H; Kinosada Y; Nakamura M
Yakugaku Zasshi; 2014; 134(2):299-304. PubMed ID: 24492232
[TBL] [Abstract][Full Text] [Related]
6. Treating type 2 diabetes: targeting the many causative factors.
Sutherland JE; Hoehns JD
J Fam Pract; 2004 May; 53(5):376-88. PubMed ID: 15125823
[No Abstract] [Full Text] [Related]
7. [Oral hypoglycemic therapy of diabetes mellitus].
Montenero P
Minerva Med; 1976 Jan; 67(3):208-15. PubMed ID: 1250219
[No Abstract] [Full Text] [Related]
8. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
[No Abstract] [Full Text] [Related]
9. Rosiglitazone + glimepiride: new drug. Another combination product to avoid.
Prescrire Int; 2007 Aug; 16(90):144. PubMed ID: 17726795
[No Abstract] [Full Text] [Related]
10. Controlling diabetes with diet and oral hypoglycemic agents.
Faludi G
Geriatrics; 1976 Oct; 31(10):67-70. PubMed ID: 964602
[No Abstract] [Full Text] [Related]
11. Oral antihyperglycemic therapy for type 2 diabetes mellitus.
Cheng AY; Fantus IG
CMAJ; 2005 Jan; 172(2):213-26. PubMed ID: 15655244
[TBL] [Abstract][Full Text] [Related]
12. [Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
Pernet A; Bäbler M; Ganz K
Schweiz Rundsch Med Prax; 1986 May; 75(21):626-8. PubMed ID: 3726361
[No Abstract] [Full Text] [Related]
13. Progressing From Metformin to Sulfonylureas or Meglitinides.
Grant JS; Graven LJ
Workplace Health Saf; 2016 Sep; 64(9):433-9. PubMed ID: 27621259
[TBL] [Abstract][Full Text] [Related]
14. Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.
Sun GE; Wells BJ; Yip K; Zimmerman R; Raghavan D; Kattan MW; Kashyap SR
Diabetes Obes Metab; 2014 Mar; 16(3):276-83. PubMed ID: 24199848
[TBL] [Abstract][Full Text] [Related]
15. Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
Hermansen K; Mortensen LS
Drug Saf; 2007; 30(12):1127-42. PubMed ID: 18035865
[TBL] [Abstract][Full Text] [Related]
16. Oral agents in the management of type 2 diabetes mellitus.
Luna B; Feinglos MN
Am Fam Physician; 2001 May; 63(9):1747-56. PubMed ID: 11352285
[TBL] [Abstract][Full Text] [Related]
17. Treatment of type 2 diabetes mellitus: pharmacologic intervention.
McCormick M; Quinn L
J Cardiovasc Nurs; 2002 Jan; 16(2):55-67. PubMed ID: 11800068
[TBL] [Abstract][Full Text] [Related]
18. Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
Purnell JQ; Weyer C
Treat Endocrinol; 2003; 2(1):33-47. PubMed ID: 15871553
[TBL] [Abstract][Full Text] [Related]
19. Oral hypoglycemic agents.
Ferner RE
Med Clin North Am; 1988 Nov; 72(6):1323-35. PubMed ID: 3054355
[TBL] [Abstract][Full Text] [Related]
20. Oral hypoglycemic agents in type II diabetes mellitus.
Lubbos H; Miller JL; Rose LI
Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]